Citigroup (C:NYS) and Regeneron Pharmaceuticals (REGN:NAS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com/registration2.aspx

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
C Citigroup Inc 4 1 3 0 2 0 3.5000 3.3000 Hold
HUM Humana Inc 3 0 4 0 1 0 3.5000 3.2500 Hold
TYL Tyler Technologies Inc 2 0 0 0 0 0 5.0000 4.3333 Buy
NRZ New Residential Investment Corp 1 0 0 0 0 0 5.0000 4.0000 Buy
AN AutoNation Inc 2 0 4 0 1 0 3.2857 3.0000 Hold
YELP Yelp Inc 3 0 4 0 2 0 3.2222 3.2000 Hold
EGO Eldorado Gold Corp 5 3 2 0 0 0 4.3000 4.2000 Outperform
AHP Ashford Hospitality Prime Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
VSN Veresen Inc 3 0 3 0 1 0 3.5714 3.2500 Outperform
ELD Eldorado Gold Corp 5 3 2 0 0 0 4.3000 4.2000 Outperform
AD Alaris Royalty Corp 3 2 3 0 0 0 4.0000 3.8889 Outperform
SWY Stornoway Diamond Corp 2 1 1 0 0 0 4.2500 4.2000 Outperform
RAY.A Stingray Digital Group Inc 3 0 0 0 0 0 5.0000 4.3333 Buy
DEE Delphi Energy Corp 3 2 0 0 0 0 4.6000 4.5000 Buy
RAY.B Stingray Digital Group Inc 3 0 0 0 0 0 5.0000 4.3333 Buy
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
TVL Traverse Energy Ltd 1 0 0 0 0 0 5.0000 4.0000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
REGN Regeneron Pharmaceuticals Inc 6 1 1 0 0 0 4.6250 4.4444 Buy
EXPE Expedia Inc 6 1 0 0 0 0 4.8571 4.6250 Buy
CERN Cerner Corp 3 0 5 0 0 0 3.7500 3.6667 Outperform
AMD Advanced Micro Devices Inc 1 0 5 0 2 0 2.7500 2.7143 Hold
TRMB Trimble Inc 1 0 1 0 0 0 4.0000 3.6667 Outperform
CAVM Cavium Inc 4 0 3 0 0 0 4.1429 4.0000 Outperform
IRBT iRobot Corp 0 0 1 0 0 0 3.0000 2.0000 Hold
FBNC First Bancorp 1 0 2 0 0 0 3.6667 3.0000 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

C:NYS Citigroup

http://www.citigroup.com
Citigroup has 219000 employees and is headquartered in United States.
Citigroup Inc is a financial-services company with business spanning more than 100 countries. Its core business is providing banking services, investment banking, cash management, and various other products and services.

REGN:NAS Regeneron Pharmaceuticals

http://www.regeneron.com
Regeneron Pharmaceuticals has 5400 employees and is headquartered in United States.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.